Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Cytotherapy|July 6, 2020
Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantationIchelle van Roessel, Susan Prockop, Elizabeth Klein, et al.Journal of Virology|January 29, 2003
Identification of small molecule compounds that selectively inhibit varicella-zoster virus replicationRobert J Visalli, Jeanette Fairhurst, Shamala Srinivas, et al.Transplantation and Cellular Therapy|October 9, 2022
Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell TransplantationEllen Fraint, Sana Farooki, Elizabeth Klein, et al.Transplantation and Cellular Therapy|April 21, 2024
Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult PatientsNancy A Kernan, Elizabeth Klein, Audrey Mauguen, et al.Cytotherapy|March 2, 2024
Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantationHannah Major-Monfried, Kinga Hosszu, Devin P McAvoy, et al.Journal of Medicinal Chemistry|April 4, 2007
Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymeraseThomas Nittoli, Kevin Curran, Shabana Insaf, et al.Journal of Medicinal Chemistry|November 10, 2009
Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituentJeroen C Verheijen, David J Richard, Kevin Curran, et al.Blood|November 19, 2024
Development of ALL-Hematotox: predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemiaMonica S Nair, Sara K Silbert, Kai Rejeski, et al.Journal of Medicinal Chemistry|December 23, 2009
Design and synthesis of novel diaminoquinazolines with in vivo efficacy for beta-catenin/T-cell transcriptional factor 4 pathway inhibitionChristoph M Dehnhardt, Aranapakam M Venkatesan, Zecheng Chen, et al.Cancer Research|July 9, 2009
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycinKer Yu, Lourdes Toral-Barza, Celine Shi, et al.Pageof 4